This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Discovery Corporation Appoints John Hadden Senior Vice President Of National And International Business Development

Health Discovery Corporation (OTCBB: HDVY) today announced the appointment of John R. Hadden to the position of Senior Vice President of National and International Business Development. An industry veteran with more than 26 years experience, Hadden brings to Health Discovery Corporation (HDC) a record of innovation and successes in the laboratory and healthcare fields. In his new role, Hadden is tasked with sales leadership and licensing of the Company’s products and technologies to clinical labs and medical diagnostics testing companies world-wide. He is also responsible for developing strategic alliances with these and other partners.

Most recently with Quest Diagnostics (NYSE: DGX), one of the largest commercial clinical laboratories in the world, Mr. Hadden oversaw a variety of wide-ranging assignments that included new product introductions, sales leadership, strategic alliances, and mergers and acquisitions. A former “Best of Quest” award winner, Mr. Hadden excelled at Quest for nearly eight years.

Prior to Quest Diagnostics, Mr. Hadden was Senior Vice President of Business Development at American Medical Laboratories, Inc. which was acquired by Quest Diagnostics in a transaction valued at $500 million. In addition, Mr. Hadden was Senior Vice President of National Business Development with LabOne, Inc. which was acquired by Quest Diagnostics in a transaction valued at $934 million. He also served as Associate Vice President for Laboratory Corporation of America (LabCorp).

“Throughout an impressive career with global, national and regional commercial clinical laboratories, John has accomplished a striking track record of success in all areas, from new product launches and sales leadership to mergers and acquisitions,” notes Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation. “We are thrilled to have his expertise to catapult the commercialization of Health Discovery’s products and technologies and to create strategic alliances driving the future of the Company.”

“I am honored to join Health Discovery Corporation and its distinguished team of world-renowned leaders and innovators at this very exciting time in the Company's development and commercialization cycle,” stated John Hadden, Senior Vice President for National and International Business Development. “I look forward to working closely with Dr. Barnhill to help bring commercial success to the tremendous pipeline of products, as well as developing strategic relationships to advance the goals of the Company.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 0.00%
FB $117.81 0.00%
GOOG $701.43 0.00%
TSLA $211.53 0.00%
YHOO $36.94 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs